Testing Home-Delivered Groceries to Help Lower High Blood Pressure

Trial details

Who runs it

Beth Israel Deaconess Medical Center

Trial code

NCT06891911

Record updated

19 August 2026

Original description

GoFreshSE is a randomized control trial, testing the effects of a home-delivered, dietitian-assisted, DASH-patterned grocery intervention on blood pressure in adults with high blood pressure in Florida, Georgia, and Tennessee.Read full original descriptionShow less

Groceries for Residents of Southeastern USA to Stop Hypertension

GoFreshSE is a randomized control trial, testing the effects of a home-delivered, dietitian-assisted, DASH-patterned grocery intervention on blood pressure in adults with high blood pressure in Florida, Georgia, and Tennessee.

Inclusion: Resting systolic blood pressure of 120 to <160 mm Hg and diastolic blood pressure <110 mm Hg; Resident of Florida, Georgia, and Tennessee; Able to receive home-delivered groceries or pick them up at a convenient location and willing to eat only the groceries provided over a 4-week period; Have access to refrigeration, cooking appliances, and Wi-Fi/cellular service; Have access to mobile device or computer to be able to conduct grocery orders via video conference and send/receive text messages; Willing and able to complete required measurement procedures; Able to provide consent for the study; Has access to a primary care team, urgent care center, or emergency room the study team can refer to for follow up care if warranted during the study.

Exclusion: Medication Exclusions:; Unstable doses (i.e. a change in the 6 months prior to screening or randomization or planning to start within study period) of the following:; Chronic oral corticosteroid (intermittent use is okay); Weight loss medications (non-GLP-1 receptor agonists); Sulfonylurea or any insulin use; Any medication not compatible with participation as determined by the investigators; Self-reported weight loss or gain of 15 pounds during prior 2 months; Active cardiovascular disease or any event in the prior 6 months, including coronary artery bypass grafting (CABG), percutaneous transluminal coronary angioplasty (PTCA), myocardial infarction (MI), cerebrovascular accident (CVA), or congestive heart failure (CHF) exacerbation requiring hospital admission; Gastrointestinal surgery or history that affects nutrition absorption or requires a specific diet that will deter DASH diet adherence; Anticipated change in residence outside of eligible states prior to the end of the study; Anti-hypertension medications; Cancer diagnosis or treatment in the last 2 years (non-melanoma skin cancer or localized breast or prostate or bladder cancer not requiring systemic therapy is acceptable); Any emergency department (ED) visit for asthma or chronic obstructive pulmonary disease (COPD) in the last 6 months; Any other serious illness or condition not compatible with participation as determined by the investigators; Significant food allergies, preferences, intolerances, or dietary requirements that would interfere with diet adherence; Active substance use disorder that would interfere with participation; Laboratory Exclusions:; Serum potassium ≥5.4 mmol/L or <3.5 mmol/L; Estimated glomerular filtration rate (eGFR) <30 mL/min per 1.73 m\^2 by the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation; Hemoglobin A1c ≥6.5%; Sodium-glucose co-transporter 2 (SGLT2) inhibitors; Glucose lowering medications; Use of any of the following medications:; Potassium supplement, except if part of a multivitamin; Families with more than 6 adults at dinner time (children count as half an adult); GLP-1 and dual GLP-1/GIP receptor agonists; Warfarin (Coumadin); Physical Exclusions:; Systolic blood pressure: <120 or ≥160 mm Hg or diastolic blood pressure ≥110 mm Hg; Arm circumference >52 cm (or the upper limit of the validated BP device); Medical History Exclusions:; Pregnancy or lactation or planned pregnancy during the study period; Hypoglycemia hospitalization in the last 12 months; Lifestyle and Other Exclusions:; Consumption of more than 14 alcoholic drinks per week or consumption of more than 6 drinks on one or more occasion per week; Extreme food insecurity; Participation in or planning to start weight loss program; Current participation in another clinical trial that could interfere with the study protocol; Investigator discretion.

ClinicalTrials.gov NCT06891911